Collectively, the CEOs of 177 health care companies made $2.6 billion USD in 2018. This is about $700 million USD more than what the National Institutes of Health spent conducting research on Alzheimer’s disease in the very same year.

Why This is Important: The compensation packages uncover the health care system’s real agenda. Finding ways to boost revenue and stock value by raising prices, filling more hospital beds and selling more drugs, services and devices.

Fourteen CEOs made more the $46 million each, with the highest paid CEO, Leonard Schleifer of Regeneration Pharmaceuticals raking in $118 million.

Notable Quotes: a spokesman said Schleifer “has built Regeneron from a start-up into a leading innovative biopharmaceutical company” and that he “generally holds his option awards until nearly the end of the full 10-year option term.”